Antibiotech
Software for Reducing the Overuse of Antibiotics
Company Overview
Snapshot
Founded in January 2019 by Eran Price and Dr. Uri Keler, Antibiotech operated with 1–10 employees. The company ceased operations in August 2020.
Business overview
Antibiotech develops software designed to combat the misuse and overuse of antibiotics. The company's core technology leverages predictive analytics to process real-time patient data from electronic medical records, providing prescribing physicians with patient-specific treatment recommendations. These recommendations focus on optimal empiric antibiotic treatments before definitive culture data becomes available. Antibiotech's solutions aim to reduce avoidable medication costs, decrease hospital-acquired infections, and shorten patient lengths of stay within the Health Tech & Life Sciences sector, specifically targeting the Digital Healthcare and Medical Decision Support markets.
Log in to access full profile ›Company Intelligence Q&A
- What is Antibiotech's primary mission?
- Antibiotech's primary mission is to reduce the misuse and overuse of antibiotics by providing physicians with patient-specific treatment recommendations.
- When was Antibiotech founded?
- Antibiotech was founded in January 2019.
- Who are the founders of Antibiotech?
- Antibiotech was founded by Eran Price, who served as Co-founder & CEO, and Dr. Uri Keler, who was Co-founder & VP Product.
- What technology does Antibiotech utilize?
- Antibiotech's software incorporates predictive analytics capabilities to analyze real-time patient data from electronic medical records, informing its treatment recommendations.
- What is the current operational status of Antibiotech?
- Antibiotech ceased operations in August 2020.